News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
237 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (37443)
2025 (32532)
Month
January (4451)
February (4428)
March (5683)
April (4545)
May (5703)
June (4805)
July (3912)
August (4762)
September (4260)
October (3860)
November (4837)
December (2683)
Day
1 (154)
2 (6)
3 (12)
4 (274)
5 (260)
6 (237)
7 (220)
8 (212)
9 (3)
10 (10)
11 (235)
12 (224)
13 (213)
14 (181)
15 (49)
16 (1)
18 (153)
19 (254)
20 (233)
21 (215)
22 (111)
23 (5)
24 (5)
25 (226)
26 (269)
27 (322)
28 (307)
29 (150)
30 (4)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
18
19
20
21
22
23
24
25
26
27
28
29
30
Business
Leen Kawas Business Partner Stirs Up More Drama at Athira
Athira Pharma is circling the wagons and urging shareholders to reject investor Richard Kayne’s calls for a management change.
April 6, 2022
·
3 min read
·
Alex Keown
Business
Esteemed Harvard Researcher Heads to Vertex to Curate Diabetes Portfolio
Noted Harvard researcher Doug Melton is heading to Vertex Pharmaceuticals to head up investigations into potential transformative treatments for type 1 diabetes.
April 6, 2022
·
2 min read
·
Alex Keown
Business
Boehringer Ingelheim Addresses Ukraine Crisis while Projecting 15 Launches by 2025
Boehringer Ingelheim made a splash on Tuesday, announcing its intention to pump €25 billion ($27 billion) into its R&D pipeline over the next five years.
April 6, 2022
·
3 min read
·
Heather McKenzie
Business
BioSpace Looks at the Top 8 Biopharma Companies by Net Income
Here’s a look at the eight most profitable biopharma companies around the world. Profitability, in this case, refers to net income, as opposed to total revenue or sales.
April 6, 2022
·
3 min read
·
Mark Terry
Business
Robotics Startup Galen Snags Moderna Legend Robert Langer
Galen Robotics will further benefit from Robert Langer’s extensive experience in biotech startups and hands-on laboratory work.
April 6, 2022
·
2 min read
·
Hannah Chudleigh
Business
Global Roundup: Ginkgo/Microba Autoimmune Pact and New Parkinson’s Data
Biopharma and life sciences organizations from across the globe provide updates on their businesses and pipelines.
April 6, 2022
·
7 min read
·
Alex Keown
Drug Development
Kintor’s Antiviral Demonstrates Broad Protection in Mild to Moderate COVID-19
The data demonstrated that the drug, when given to the patients for more than seven days, offered a protection rate of 100%.
April 6, 2022
·
3 min read
·
Mark Terry
Discovery of New Lung Cell Could Lead to Breakthroughs in COPD
Researchers at the Perelman School of Medicine at the University of Pennsylvania have discovered a novel type of cell buried in healthy human lung tissue.
April 6, 2022
·
2 min read
·
Jazmine Colatriano M.S.
Drug Development
Novartis Augments Transformational Week with US Approval, European Milestones
With the accelerated approval from the U.S. Food and Drug Administration, Vijoice becomes the first treatment approved in the United States for PROS
April 6, 2022
·
3 min read
·
Alex Keown
Drug Development
Armed with Robust Data, Citius Will Seek Approval in T-cell lymphoma
Citius Pharmaceuticals has shared positive topline data from its Phase III clinical trial of I/Ontak. The company plans to file a biologics license application with the FDA later this year.
April 6, 2022
·
2 min read
·
Hayley Shasteen
1 of 24
Next
